authorised the use of the patent during the COVID-19 pandemic. BioNTech and Pfizer claimed this authorisation was valid until 5 May 2023 when the World Health Organisation declared the COVID-19 pandemic
March 5 - Pfizer (PFE.N) and BioNTech (22UAy.DE) won a round in their legal battle with Moderna (MRNA.O) over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two